In a Presidential Commission for the Study of Bioethical Issues meeting session dedicated to the potential applications of synthetic biology post-Mycoplasma mycoides JCVI-syn1.0, Craig Venter, George Church, and Kristala Prather spoke about innovation and collaboration. Amy Gutmann, chair of the Commission, was particularly interested in the emerging potential public health benefits of synthetic genomics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.